Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Investigation of angiogenetic markers (ENA-78 and GRO-α) in patients with pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005
Steroid-induced BAL lymphocyte (L-BAL) apoptosis as prognostic factor in patients with bronchial asthma (AB) Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Concentration of NO2-, a-acid protein (AAP), tumor necrotic factor (TNF-a), in the induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB) Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007
Enhanced expression of interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial (AE) cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
The typing of cells in the induced sputum (IS) and its apoptosis in patients with bronchial asthma (BA) Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020
Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD Source: Annual Congress 2003 - From gene to breath analysis in airway disorders Year: 2003
Polymorphism of multidrug resistance gene (MDR1), interleukin 4 (IL4), IL13 genes in asthmatic patients and patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Measurement of tumor necrosis factor (TNF)α, leukotriene B4 (LTB4), and interleukin 8 (IL8) in the exhaled breath condensate (EBC) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Inflammatory-cellular composition of the induced sputum (IS) and activity of leucocytes myeloperoxidase (MPO) in asthmatics with different airway response to hyperosmolar stimulus Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
BAL features in patients with systemic scleroris (SSc) Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF) Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011